This inventor holds 1 USPTO granted patent. Top assignee: Eastman Kodak. Active years: 1990.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1990
Title: Innovations in Nitrate Therapy by Gerald W Bayer
Introduction
Gerald W Bayer is an accomplished inventor based in Rochester, NY (US). He has made significant contributions to the field of medical treatment, particularly in the area of nitrate therapy for angina pectoris. His innovative approach addresses the frequent need for patients to manage pre-waking or early morning angina effectively.
Latest Patents
Gerald W Bayer holds a patent for a method and device for treating angina pectoris and preventing tolerance to nitrate drugs. This patent outlines a treatment regimen that involves administering a daily unit dose of nitrate before bedtime. The method ensures a washout period of 3 to 12 hours, during which the delivery of nitrate is sufficiently retarded to prevent tolerance. The treatment then initiates an effective delivery period before the patient expects to awaken, followed by a ramp-up delivery period that increases the nitrate delivery rate. This innovative approach is designed to enhance patient outcomes and improve the management of angina symptoms.
Career Highlights
Gerald W Bayer is associated with Eastman Kodak, where he has applied his expertise in developing medical treatments. His work has contributed to advancements in patient care and the management of cardiovascular conditions.
Collaborations
Throughout his career, Gerald has collaborated with notable colleagues, including Paul F Schmit and Paul A Diamantopoulos. These collaborations have fostered innovation and the sharing of ideas in the medical field.
Conclusion
Gerald W Bayer's contributions to nitrate therapy represent a significant advancement in the treatment of angina pectoris. His innovative methods and dedication to improving patient care highlight the importance of ongoing research and development in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile